The Marlene and Stewart Greenebaum Family Foundation has donated $5.5 million to the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) to advance scientific research and compassionate, state-of-the-art cancer care. The comprehensive cancer center is named in honor of Marlene and Stewart Greenebaum, who made a transformative gift 30 years ago following Mrs. Greenebaum’s successful treatment for breast cancer.
The funds will foster research conducted by faculty at the University of Maryland School of Medicine and advance innovative treatments, such as using immunotherapies like CAR T-cells to treat solid tumors. The donation will also strengthen UMGCCC’s support for cancer survivors through investigation of effective uses for emerging wearable technologies, specialized care to improve quality of life, and tailored nutritional support.
UMGCCC is poised for major expansion with its move into the Stoler Center for Advanced Medicine in fall 2026. In recognition of the Greenebaums’ legacy, the lobby of the new building will be named in the family’s honor, serving as the main entrance to the University of Maryland Medical Center at 22 S. Greene Street.
Marlene Greenebaum lived 28 years after her breast cancer diagnosis, benefiting from extraordinary medical care at the University of Maryland Medical Center. She was treated with an aromatase inhibitor, a drug invented by Angela Brodie, Ph.D., a preeminent breast cancer researcher at the cancer center.
The UMGCCC received national designation as an NCI Cancer Center in 2008 and the highest recognition possible when designated as a comprehensive cancer center in 2016, with renewal of the designation in 2021.
Recent growth has been substantial. Patient volume at UMGCCC has increased by more than 50% over the past two decades, with more than 3,700 new patients treated annually and over 60,000 outpatient visits. The center’s oncology faculty now lead more than 450 clinical trials—more than twice the number from earlier years—and research funding has grown to over $130 million annually. The facility is ranked among the top 50 cancer programs in the country by U.S. News & World Report.
Michael Greenebaum, a business leader, philanthropist, and Chair of the University of Maryland School of Medicine’s Board of Visitors, stated that the latest gift marks a meaningful way to celebrate the 30th anniversary of his parents’ founding contribution while marking a pivotal moment for the cancer center.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.newswise.com/articles/greenebaum-family-donates-5-5-million-to-advance-cancer-research-and-patient-care/?sc=rsmn